| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Mr. Marc Lloret-Grau CEO | XMUN Exchange | DE000BGAG981 ISIN |
| Germany Country | - Employees | - Last Dividend | 28 Jul 2026 Last Split | - IPO Date |
Bio-Gate AG is a prominent company headquartered in Nuremberg, Germany, specializing in the development of technologies and tailored solutions aimed at enhancing health and hygiene standards. Since its establishment in 2005, the company has been at the forefront of integrating advanced materials and solutions into products designed to combat microbial contamination and promote sterile environments. Operating primarily in Germany, Bio-Gate AG caters to a wide range of clients, including large and medium-sized entities within the medical technology sector, pharmaceutical distributors, various industrial companies, public sector entities, and institutions with a critical need for maintaining high hygiene standards.
Bio-Gate AG has developed a suite of innovative products and technology solutions focused on microbial resistance and hygiene enhancement, notably: